NTDT
Showing 1 - 11 of 11
Thalassemia Trial in Worldwide (Luspatercept, Placebo, Best Supportive Care (BSC))
Active, not recruiting
- Thalassemia
- Luspatercept
- +2 more
-
Los Angeles, California
- +16 more
Aug 16, 2022
Hemoglobinopathies and Rare Inherited Anemia and Covid 19
Recruiting
- Haemoglobinopathies
-
Genova, Italy
- +1 more
May 4, 2022
Transfusion-dependent Thalassemia Trial in Dhaka (Thalidomide Capsules, Placebo)
Recruiting
- Transfusion-dependent Thalassemia
- Thalidomide Capsules
- Placebo
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
Oct 18, 2023
Anemia Trial in Worldwide (biological, drug, other)
Recruiting
- Anemia
- Luspatercept
- +2 more
-
Halifax, Nova Scotia, Canada
- +11 more
Jan 3, 2023
Transfusion-dependent Thalassemia, Non-transfusion-dependent Thalassemia Trial in Worldwide (Deferasirox dispersable tablet
Completed
- Transfusion-dependent Thalassemia
- Non-transfusion-dependent Thalassemia
- Deferasirox dispersable tablet (DT)
- Deferasirox film coated tablet (FCT)
-
Alexandria, Egypt
- +16 more
Sep 6, 2021
Beta-Thalassemia Trial in Chiang Mai (EPEG)
Completed
- Beta-Thalassemia
-
Chiang Mai, ThailandFaculty of Medicine, Chiang Mai University
May 23, 2018
Non-transfusion Dependent Thalassemia Trial in Worldwide (deferasirox)
Completed
- Non-transfusion Dependent Thalassemia
-
Nanning, Guangxi, China
- +10 more
Sep 19, 2019
Adiponectin, IL-6 and hsC-RP in Relation to Carotid Intima-media
Completed
- Thalassemia
- Interleukin-6
- +3 more
-
Assiut, EgyptAssiut University Hospital
Feb 15, 2021
Thalassemia Trial in Nanjing (Thalidomide)
Unknown status
- Thalassemia
-
Nanjing, Guangxi, ChinaNO.3 Hospital of the Chinese People's Liberation Army
Mar 21, 2017
Thalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other Anemia Trial in Australia (MRI
Completed
- Thalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other Anemia
- MRI scan
-
Camperdown, New South Wales, Australia
- +12 more
Mar 14, 2017